Maria Cecilia Bahit

1.4k total citations · 1 hit paper
18 papers, 837 citations indexed

About

Maria Cecilia Bahit is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering. According to data from OpenAlex, Maria Cecilia Bahit has authored 18 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 3 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Biomedical Engineering. Recurrent topics in Maria Cecilia Bahit's work include Acute Myocardial Infarction Research (7 papers), Heart Failure Treatment and Management (6 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Maria Cecilia Bahit is often cited by papers focused on Acute Myocardial Infarction Research (7 papers), Heart Failure Treatment and Management (6 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Maria Cecilia Bahit collaborates with scholars based in United States, Argentina and Canada. Maria Cecilia Bahit's co-authors include Christopher B. Granger, Ajar Kochar, Santosh B. Murthy, Cheng‐Yang Hsieh, Luciano A. Sposato, Sara Aspberg, Jan F. Scheitz, Max J. Hilz, Mary N. Sheppard and Christopher M. O’Connor and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Cardiology and American Heart Journal.

In The Last Decade

Maria Cecilia Bahit

17 papers receiving 824 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Post-Myocardial Infarction Heart Failure

2018 292 citations Maria Cecilia Bahit, Ajar Kochar et al. JACC Heart Failure profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maria Cecilia Bahit United States	9	617	141	117	116	101	18	837
Gavino Casu Italy	16	342 0.6×	151 1.1×	89 0.8×	78 0.7×	111 1.1×	75	720
Raphael Wurm Austria	15	436 0.7×	164 1.2×	126 1.1×	46 0.4×	58 0.6×	49	769
Daniele Masarone Italy	16	647 1.0×	138 1.0×	91 0.8×	75 0.6×	77 0.8×	73	858
Emilia D’Elia Italy	14	684 1.1×	140 1.0×	88 0.8×	40 0.3×	125 1.2×	56	936
Yun Gi Kim South Korea	21	890 1.4×	135 1.0×	83 0.7×	106 0.9×	63 0.6×	83	1.2k
Giulio Russo Italy	19	581 0.9×	315 2.2×	175 1.5×	204 1.8×	128 1.3×	62	949
Moriaki Inoko Japan	16	710 1.2×	217 1.5×	81 0.7×	128 1.1×	132 1.3×	98	1.1k
Fragiskos Parthenakis Greece	20	803 1.3×	262 1.9×	145 1.2×	130 1.1×	152 1.5×	84	1.3k
Norihisa Toh Japan	18	575 0.9×	157 1.1×	227 1.9×	78 0.7×	299 3.0×	72	962
Luigi Tavazzi Italy	13	1.1k 1.7×	200 1.4×	48 0.4×	92 0.8×	77 0.8×	20	1.3k

Countries citing papers authored by Maria Cecilia Bahit

Since Specialization

Citations

This map shows the geographic impact of Maria Cecilia Bahit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Cecilia Bahit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Cecilia Bahit more than expected).

Fields of papers citing papers by Maria Cecilia Bahit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Cecilia Bahit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Cecilia Bahit. The network helps show where Maria Cecilia Bahit may publish in the future.

Co-authorship network of co-authors of Maria Cecilia Bahit

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Cecilia Bahit. A scholar is included among the top collaborators of Maria Cecilia Bahit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Cecilia Bahit. Maria Cecilia Bahit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Gibson, C. Michael, Maria Cecilia Bahit, Roxana Mehran, et al.. (2025). Oral factor xia inhibitor milvexian after a recent acute coronary syndrome: Rationale and design of the phase 3 (Librexia ACS). American Heart Journal. 285. 21–28. 4 indexed citations

Capodanno, Davide, John H. Alexander, Maria Cecilia Bahit, et al.. (2025). Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism. Nature Reviews Cardiology. 22(11). 896–912. 5 indexed citations

Bahit, Maria Cecilia, Michael K. Gibson, Łukasz Szarpak, et al.. (2025). Vision impairment following glucagon-like peptide-1 receptor agonist use: is it harmful?. Polskie Archiwum Medycyny Wewnętrznej. 135(4).

Sposato, Luciano A., Alan C. Cameron, Michelle C. Johansen, et al.. (2024). Ischemic stroke prevention in patients with atrial fibrillation and a recent ischemic stroke, TIA, or intracranial hemorrhage: A World Stroke Organization (WSO) scientific statement. International Journal of Stroke. 20(4). 385–400. 1 indexed citations

Januzzi, James L., Alka Shaunik, Maria Cecilia Bahit, et al.. (2024). Barriers and Facilitators to Implementation of Intravenous Cardiovascular Treatments in Ambulatory Settings. ESC Heart Failure. 12(1). 695–700. 1 indexed citations

Bahit, Maria Cecilia & C. Michael Gibson. (2024). Thrombin as target for prevention of recurrent events after acute coronary syndromes. Thrombosis Research. 235. 116–121. 4 indexed citations

Tromp, Jasper, Carolyn S.P. Lam, Wendimagegn Alemayehu, et al.. (2024). Biomarker Profiles Associated with Reverse Ventricular Remodelling in Patients with Heart Failure and a Reduced Ejection Fraction: Insights from the Echocardiographic Substudy of the VICTORIA Trial. European Journal of Heart Failure. 26(10). 2231–2239. 1 indexed citations

Pieske, Burkert, Elisabeth Pieske‐Kraigher, Carolyn S.P. Lam, et al.. (2023). Effect of Vericiguat on Left Ventricular Structure and Function in Patients with Heart Failure with Reduced Ejection Fraction: The VICTORIA Echocardiographic Substudy. European Journal of Heart Failure. 25(7). 1012–1021. 17 indexed citations

Sposato, Luciano A., Max J. Hilz, Sara Aspberg, et al.. (2020). Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury. Journal of the American College of Cardiology. 76(23). 2768–2785. 179 indexed citations

10.

Bahit, Maria Cecilia, Ajar Kochar, & Christopher B. Granger. (2018). Post-Myocardial Infarction Heart Failure. JACC Heart Failure. 6(3). 179–186. 292 indexed citations breakdown →

11.

Orlandini, Andrés, Noelia Castellana, Andrea Pascual, et al.. (2015). Myocardial viability for decision-making concerning revascularization in patients with left ventricular dysfunction and coronary artery disease: A meta-analysis of non-randomized and randomized studies. International Journal of Cardiology. 182. 494–499. 41 indexed citations

12.

Bahit, Maria Cecilia, Renato D. Lópes, Robert M. Clare, et al.. (2013). Heart Failure Complicating Non–ST-Segment Elevation Acute Coronary Syndrome. JACC Heart Failure. 1(3). 223–229. 42 indexed citations

13.

O’Connor, Christopher M., Alan B. Miller, John E. Blair, et al.. (2010). Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program. American Heart Journal. 159(5). 841–849.e1. 193 indexed citations

14.

Estrada, José L., et al.. (2006). NT–probrain natriuretic peptide predicts complexity and severity of the coronary lesions in patients with non–ST-elevation acute coronary syndromes. American Heart Journal. 151(5). 1093.e1–1093.e7. 18 indexed citations

15.

Bahit, Maria Cecilia, Elliott M. Antman, Sabina A. Murphy, Carolyn H. McCabe, & Christopher P. Cannon. (2002). Comparison of characteristics, treatment, and outcomes of patients enrolled versus not enrolled in a clinical trial: findings from TIMI 9 Registry and 9b trial. Journal of the American College of Cardiology. 39. 303–303. 1 indexed citations

16.

Bahit, Maria Cecilia, Sabina A. Murphy, Michael C. Gibson, & Christopher P. Cannon. (2002). Critical Pathway for Acute ST-Segment Elevation Myocardial Infarction. Critical Pathways in Cardiology A Journal of Evidence-Based Medicine. 1(2). 107–112. 4 indexed citations

17.

Bahit, Maria Cecilia, Douglas A. Criger, E. Magnus Ohman, Christopher B. Granger, & Galen S. Wagner. (2002). Thresholds for the electrocardiographic change range of biochemical markers of acute myocardial infarction (GUSTO-IIa data). The American Journal of Cardiology. 90(3). 233–237. 14 indexed citations

18.

Bahit, Maria Cecilia, Eric J. Topol, Robert M. Califf, et al.. (2001). Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Journal of the American College of Cardiology. 37(4). 1001–1007. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact